Post-Marketing Surveillance User Fees Will Hinge On Consensus - Henney
Executive Summary
User fees for post-marketing surveillance will be possible only with consensus between FDA and industry, FDA Commissioner nominee Jane Henney, MD, suggested in response to a pre-confirmation questionnaire forwarded to her by Republican members of the Senate Labor and Human Resources Committee.